TVRD
Tvardi Therapeutics
TVRD
TVRD
172 hedge funds and large institutions have $444M invested in Tvardi Therapeutics in 2021 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 53 increasing their positions, 49 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
0.08% less ownership
Funds ownership: 1.8% → 1.73% (-0.08%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
37% less capital invested
Capital invested by funds: $703M → $444M (-$259M)
Holders
172
Holding in Top 10
2
Calls
$5.8M
Puts
$5.45M
Top Buyers
| 1 | +$51.5M | |
| 2 | +$9.94M | |
| 3 | +$9.53M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.02M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.1M |
Top Sellers
| 1 | -$47.1M | |
| 2 | -$17.9M | |
| 3 | -$15.8M | |
| 4 |
RCP
Rho Capital Partners
New York
|
-$15M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$7.54M |